A Bayesian approach for the estimation of patient compliance based on the last sampling information

Olivier Barrière1, Jun Li1, Fahima Nekka1
1Faculté de Pharmacie, Université de Montréal, C.P. 6128, Succ. Centre-ville, Montréal, QC, H3C 3J7, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M (2008) Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336(7653):1114–1119

Urquhart J (2000) Erratic patient compliance with prescribed drug regimens: target for drug. Clin Pharmacol Ther 67(4):331–334

Hénin E, Tod M, Trillet-Lenoir V, Rioufol C, Tranchand B, Girard P (2009) Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation. Clin Pharmacokinet 48(6):359–369

Li J, Nekka F (2007) A pharmacokinetic formalism explicitly integrating the patient drug compliance. J Pharmacokinet Pharmacodyn 34(1):115–139

Mu S, Ludden TM (2003) Estimation of population harmacokinetic parameters in the presence of non-compliance. JPKPD 30(1):53–81

Soy D, Beal SL, Sheiner LB (2004) Population one-compartment pharmacokinetic analysis with missing dosage data. Clin Pharmacol Ther 76(5):441–451

Jonsson EN, Wade JR, Almqvist G et al (1997) Discrimination between rival dosing histories. Pharm Res 14(8):984–991

Girard P, Sheiner L, Kastrissios H, Blaschke T (1996) Do we need full compliance data for population pharmacokinetic analysis?. J Pharmacokinet Biopharm 24(3):265–282

Vrijens B, Goetghebeur E (2004) Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies. Stat Med 23(4):531–544

Li J, Nekka F (2009) A probabilistic approach for the evaluation of pharmacological effect induced by patient irregular drug intake. J Pharmacokinet Pharmacodyn 36(3):221–246

Widmer N, Decosterd LA, Csajka C, Leyvraz S, Duchosal MA, Rosselet A, Rochat B, Eap CB, Henry H, Biollaz J, Buclin T (2006) Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein. Br J Clin Pharmacol 62(1):97–112

Duda RO, Hart PE, Stork DG (2001) Pattern classification, 2nd edn. Wiley, New York